Yoko Tanimoto

Novel embryonic stem cells expressing tdKaede protein photoconvertible from green to red fluorescence.

Embryonic stem cells derived from C57BL/6J and C57BL/6N mice.

Effect of different culture conditions on establishment of embryonic stem cells from BALB/cAJ and NZB/BINJ mice.

Novel ROSA26 Cre-reporter knock-in C57BL/6N mice exhibiting green emission before and red emission after Cre-mediated recombination.

Generation and characterization of Ins1-cre-driver C57BL/6N for exclusive pancreatic beta cell-specific Cre-loxP recombination.

Simple generation of albino C57BL/6J mice with G291T mutation in the tyrosinase gene by the CRISPR/Cas9 system.

Peri-implantation lethality in mice carrying megabase-scale deletion on 5qc3.3 is caused by Exoc1 null mutation.

Combined Overexpression of JARID2, PRDM14, ESRRB, and SALL4A Dramatically Improves Efficiency and Kinetics of Reprogramming to Induced Pluripotent Stem Cells.

Generation of CRISPR/Cas9-mediated bicistronic knock-in ins1-cre driver mice.

H1foo Has a Pivotal Role in Qualifying Induced Pluripotent Stem Cells.

Simple generation of hairless mice for in vivo imaging.

Important cardiac transcription factor genes are accompanied by bidirectional long non-coding RNAs.

Generation of bicistronic reporter knockin mice for visualizing germ layers.

Generation of B6-Ddx4 , a novel CreERT2 knock-in line, for germ cell lineage by CRISPR/Cas9.

Efficient production of large deletion and gene fragment knock-in mice mediated by genome editing with Cas9-mouse Cdt1 in mouse zygotes.

Characterization of a bicistronic knock-in reporter mouse model for investigating the role of CABLES2 in vivo.

Disruption of entire locus leads to embryonic lethality by diminished gene expression and enhanced p53 pathway.

EXOC1 plays an integral role in spermatogonia pseudopod elongation and spermatocyte stable syncytium formation in mice.

Efficient induction of proximity-dependent labelling by biotin feeding in BMAL1-BioID knock-in mice.

DAJIN enables multiplex genotyping to simultaneously validate intended and unintended target genome editing outcomes.